project id: TCGA-SKCM; case submitter id: TCGA-FS-A4FC; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.77; rna integrity number: 9.5; age at index: 75; days to birth: -27482; days to death: 1655; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1932; age at diagnosis: 27482; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1504.0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1908; initial weight: 210.0; oct embedded: false; preservation method: Unknown; sample id: df558928-53b4-4b93-bcdd-30ca9043108f; sample submitter id: TCGA-FS-A4FC-06A; portion id: 20da07f4-0f4c-4a32-ab41-e16f38c968b7; portion submitter id: TCGA-FS-A4FC-06A-11; slide id: e2e93a86-f225-4d91-a131-deceb4e88d2a; slide submitter id: TCGA-FS-A4FC-06A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; section location: TOP;